| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:PRUNE-ARNT |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: PRUNE-ARNT | FusionPDB ID: 69361 | FusionGDB2.0 ID: 69361 | Hgene | Tgene | Gene symbol | PRUNE | ARNT | Gene ID | 58497 | 375056 |
| Gene name | prune exopolyphosphatase 1 | MIA SH3 domain ER export factor 3 | |
| Synonyms | DRES-17|DRES17|H-PRUNE|HTCD37|NMIHBA|PRUNE | ARNT|D320|TANGO|TANGO1|UNQ6077 | |
| Cytomap | 1q21.3 | 1q41 | |
| Type of gene | protein-coding | protein-coding | |
| Description | exopolyphosphatase PRUNE1Drosophila-related expressed sequence 17protein prune homologprotein prune homolog 1 | transport and Golgi organization protein 1 homologC219-reactive peptideMIA family member 3, ER export factormelanoma inhibitory activity family, member 3melanoma inhibitory activity protein 3transport and Golgi organization protein 1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | Q8WYA1 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000467771, ENST00000271620, ENST00000271619, ENST00000368934, ENST00000368935, ENST00000368936, ENST00000368937, | ENST00000354396, ENST00000358595, ENST00000505755, ENST00000515192, ENST00000468970, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 7 X 5 X 6=210 | 9 X 6 X 6=324 |
| # samples | 8 | 9 | |
| ** MAII score | log2(8/210*10)=-1.39231742277876 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/324*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: PRUNE [Title/Abstract] AND ARNT [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | PRUNE(150991145)-ARNT(150812130), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | PRUNE-ARNT seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PRUNE-ARNT seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PRUNE-ARNT seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. PRUNE-ARNT seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | ARNT | GO:0002687 | positive regulation of leukocyte migration | 17726152 |
| Tgene | ARNT | GO:0007162 | negative regulation of cell adhesion | 17726152 |
| Tgene | ARNT | GO:0030336 | negative regulation of cell migration | 17044017 |
| Tgene | ARNT | GO:0042060 | wound healing | 17044017 |
| Fusion gene breakpoints across PRUNE (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across ARNT (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | STAD | TCGA-BR-8284-01A | PRUNE | chr1 | 150991145 | + | ARNT | chr1 | 150812130 | - |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000271620 | PRUNE | chr1 | 150991145 | + | ENST00000358595 | ARNT | chr1 | 150812130 | - | 4905 | 491 | 60 | 2588 | 842 |
| ENST00000271620 | PRUNE | chr1 | 150991145 | + | ENST00000354396 | ARNT | chr1 | 150812130 | - | 3745 | 491 | 60 | 2582 | 840 |
| ENST00000271620 | PRUNE | chr1 | 150991145 | + | ENST00000515192 | ARNT | chr1 | 150812130 | - | 2914 | 491 | 60 | 2573 | 837 |
| ENST00000271620 | PRUNE | chr1 | 150991145 | + | ENST00000505755 | ARNT | chr1 | 150812130 | - | 2649 | 491 | 60 | 2588 | 842 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000271620 | ENST00000358595 | PRUNE | chr1 | 150991145 | + | ARNT | chr1 | 150812130 | - | 0.001034256 | 0.99896574 |
| ENST00000271620 | ENST00000354396 | PRUNE | chr1 | 150991145 | + | ARNT | chr1 | 150812130 | - | 0.002216568 | 0.9977835 |
| ENST00000271620 | ENST00000515192 | PRUNE | chr1 | 150991145 | + | ARNT | chr1 | 150812130 | - | 0.004847942 | 0.995152 |
| ENST00000271620 | ENST00000505755 | PRUNE | chr1 | 150991145 | + | ARNT | chr1 | 150812130 | - | 0.007870184 | 0.99212974 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >69361_69361_1_PRUNE-ARNT_PRUNE_chr1_150991145_ENST00000271620_ARNT_chr1_150812130_ENST00000354396_length(amino acids)=840AA_BP=139 MSPGRAAFVGETSPRPGAPLLDQGRRRTLGFIMEDYLQGCRAALQESRPLHVVLGNEACDLDSTVSALALAFYLAKTTEAEEVFVPVLNI KRSELPLRGDIVFFLQKVHIPESILIFRDEIDLHALYQAGQLTLILVDHHILSKENHSEIERRRRNKMTAYITELSDMVPTCSALARKPD KLTILRMAVSHMKSLRGTGNTSTDGSYKPSFLTDQELKHLILEAADGFLFIVSCETGRVVYVSDSVTPVLNQPQSEWFGSTLYDQVHPDD VDKLREQLSTSENALTGRILDLKTGTVKKEGQQSSMRMCMGSRRSFICRMRCGSSSVDPVSVNRLSFVRNRCRNGLGSVKDGEPHFVVVH CTGYIKAWPPAGVSLPDDDPEAGQGSKFCLVAIGRLQVTSSPNCTDMSNVCQPTEFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIV EFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQEPRPTLSNTIQRPQLGPT ANLPLEMGSGQLAPRQQQQQTELDMVPGRDGLASYNHSQVVQPVTTTGPEHSKPLEKSDGLFAQDRDPRFSEIYHNINADQSKGISSSTV PATQQLFSQGNTFPPTPRPAENFSGLAPPVTIVQPSASAGQMLAQISRHSNPTQGATPTWTPTTRSGFSAQQVATQATAKTRTSQFGVGS FQTPSSFSSMSLPGAPTASPGAAAYPSLTNRGSNFAPETGQTAGQFQTRTAEGVGVWPQWQGQQPHHRSSSSEQHVQQPPAQQPGQPEVF -------------------------------------------------------------- >69361_69361_2_PRUNE-ARNT_PRUNE_chr1_150991145_ENST00000271620_ARNT_chr1_150812130_ENST00000358595_length(amino acids)=842AA_BP=139 MSPGRAAFVGETSPRPGAPLLDQGRRRTLGFIMEDYLQGCRAALQESRPLHVVLGNEACDLDSTVSALALAFYLAKTTEAEEVFVPVLNI KRSELPLRGDIVFFLQKVHIPESILIFRDEIDLHALYQAGQLTLILVDHHILSKENHSEIERRRRNKMTAYITELSDMVPTCSALARKPD KLTILRMAVSHMKSLRGTGNTSTDGSYKPSFLTDQELKHLILEAADGFLFIVSCETGRVVYVSDSVTPVLNQPQSEWFGSTLYDQVHPDD VDKLREQLSTSENALTGRILDLKTGTVKKEGQQSSMRMCMGSRRSFICRMRCGSSSVDPVSVNRLSFVRNRCRNGLGSVKDGEPHFVVVH CTGYIKAWPPAGVSLPDDDPEAGQGSKFCLVAIGRLQVTSSPNCTDMSNVCQPTEFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIV EFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQEPRPTLSNTIQRPQLGPT ANLPLEMGSGQLAPRQQQQQTELDMVPGRDGLASYNHSQVVQPVTTTGPEHSKPLEKSDGLFAQDRDPRFSEIYHNINADQSKGISSSTV PATQQLFSQGNTFPPTPRPAENFRNSGLAPPVTIVQPSASAGQMLAQISRHSNPTQGATPTWTPTTRSGFSAQQVATQATAKTRTSQFGV GSFQTPSSFSSMSLPGAPTASPGAAAYPSLTNRGSNFAPETGQTAGQFQTRTAEGVGVWPQWQGQQPHHRSSSSEQHVQQPPAQQPGQPE -------------------------------------------------------------- >69361_69361_3_PRUNE-ARNT_PRUNE_chr1_150991145_ENST00000271620_ARNT_chr1_150812130_ENST00000505755_length(amino acids)=842AA_BP=139 MSPGRAAFVGETSPRPGAPLLDQGRRRTLGFIMEDYLQGCRAALQESRPLHVVLGNEACDLDSTVSALALAFYLAKTTEAEEVFVPVLNI KRSELPLRGDIVFFLQKVHIPESILIFRDEIDLHALYQAGQLTLILVDHHILSKENHSEIERRRRNKMTAYITELSDMVPTCSALARKPD KLTILRMAVSHMKSLRGTGNTSTDGSYKPSFLTDQELKHLILEAADGFLFIVSCETGRVVYVSDSVTPVLNQPQSEWFGSTLYDQVHPDD VDKLREQLSTSENALTGRILDLKTGTVKKEGQQSSMRMCMGSRRSFICRMRCGSSSVDPVSVNRLSFVRNRCRNGLGSVKDGEPHFVVVH CTGYIKAWPPAGVSLPDDDPEAGQGSKFCLVAIGRLQVTSSPNCTDMSNVCQPTEFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIV EFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQEPRPTLSNTIQRPQLGPT ANLPLEMGSGQLAPRQQQQQTELDMVPGRDGLASYNHSQVVQPVTTTGPEHSKPLEKSDGLFAQDRDPRFSEIYHNINADQSKGISSSTV PATQQLFSQGNTFPPTPRPAENFRNSGLAPPVTIVQPSASAGQMLAQISRHSNPTQGATPTWTPTTRSGFSAQQVATQATAKTRTSQFGV GSFQTPSSFSSMSLPGAPTASPGAAAYPSLTNRGSNFAPETGQTAGQFQTRTAEGVGVWPQWQGQQPHHRSSSSEQHVQQPPAQQPGQPE -------------------------------------------------------------- >69361_69361_4_PRUNE-ARNT_PRUNE_chr1_150991145_ENST00000271620_ARNT_chr1_150812130_ENST00000515192_length(amino acids)=837AA_BP=139 MSPGRAAFVGETSPRPGAPLLDQGRRRTLGFIMEDYLQGCRAALQESRPLHVVLGNEACDLDSTVSALALAFYLAKTTEAEEVFVPVLNI KRSELPLRGDIVFFLQKVHIPESILIFRDEIDLHALYQAGQLTLILVDHHILSKENHSEIERRRRNKMTAYITELSDMVPTCSALARKPD KLTILRMAVSHMKSLRGTGNTSTDGSYKPSFLTDQELKHLILEAADGFLFIVSCETGRVVYVSDSVTPVLNQPQSEWFGSTLYDQVHPDD VDKLREQLSTSENALTGRILDLKTGTVKKEGQQSSMRMCMGSRRSFICRMRCGSSSVDPVSVNRLSFVRNRCRNGLGSVKDGEPHFVVVH CTGYIKAWPPADDDPEAGQGSKFCLVAIGRLQVTSSPNCTDMSNVCQPTEFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVEFCHP EDQQLLRDSFQQVVKLKGQVLSVMFRFRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQEPRPTLSNTIQRPQLGPTANLPL EMGSGQLAPRQQQQQTELDMVPGRDGLASYNHSQVVQPVTTTGPEHSKPLEKSDGLFAQDRDPRFSEIYHNINADQSKGISSSTVPATQQ LFSQGNTFPPTPRPAENFRNSGLAPPVTIVQPSASAGQMLAQISRHSNPTQGATPTWTPTTRSGFSAQQVATQATAKTRTSQFGVGSFQT PSSFSSMSLPGAPTASPGAAAYPSLTNRGSNFAPETGQTAGQFQTRTAEGVGVWPQWQGQQPHHRSSSSEQHVQQPPAQQPGQPEVFQEM -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:150991145/chr1:150812130) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | ARNT |
| FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress ARNTL/BMAL1 transcription, respectively. The CLOCK-ARNTL2/BMAL2 heterodimer activates the transcription of SERPINE1/PAI1 and BHLHE40/DEC1. {ECO:0000269|PubMed:11018023, ECO:0000269|PubMed:12738229, ECO:0000269|PubMed:14672706}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | PRUNE | chr1:150991145 | chr1:150812130 | ENST00000271620 | + | 3 | 8 | 106_108 | 111.66666666666667 | 454.0 | Motif | Note=DHH motif |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 503_507 | 90.66666666666667 | 790.0 | Compositional bias | Note=Poly-Gln | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 710_769 | 90.66666666666667 | 790.0 | Compositional bias | Note=Gln-rich | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 738_741 | 90.66666666666667 | 790.0 | Compositional bias | Note=Poly-Ser | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 99_102 | 90.66666666666667 | 790.0 | Compositional bias | Note=Poly-Arg | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 503_507 | 75.66666666666667 | 775.0 | Compositional bias | Note=Poly-Gln | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 710_769 | 75.66666666666667 | 775.0 | Compositional bias | Note=Gln-rich | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 738_741 | 75.66666666666667 | 775.0 | Compositional bias | Note=Poly-Ser | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 99_102 | 75.66666666666667 | 775.0 | Compositional bias | Note=Poly-Arg | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 503_507 | 81.66666666666667 | 776.0 | Compositional bias | Note=Poly-Gln | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 710_769 | 81.66666666666667 | 776.0 | Compositional bias | Note=Gln-rich | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 738_741 | 81.66666666666667 | 776.0 | Compositional bias | Note=Poly-Ser | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 99_102 | 81.66666666666667 | 776.0 | Compositional bias | Note=Poly-Arg | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 161_235 | 90.66666666666667 | 790.0 | Domain | PAS 1 | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 349_419 | 90.66666666666667 | 790.0 | Domain | PAS 2 | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 424_467 | 90.66666666666667 | 790.0 | Domain | Note=PAC | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 89_142 | 90.66666666666667 | 790.0 | Domain | bHLH | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 161_235 | 75.66666666666667 | 775.0 | Domain | PAS 1 | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 349_419 | 75.66666666666667 | 775.0 | Domain | PAS 2 | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 424_467 | 75.66666666666667 | 775.0 | Domain | Note=PAC | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 89_142 | 75.66666666666667 | 775.0 | Domain | bHLH | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 161_235 | 81.66666666666667 | 776.0 | Domain | PAS 1 | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 349_419 | 81.66666666666667 | 776.0 | Domain | PAS 2 | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 424_467 | 81.66666666666667 | 776.0 | Domain | Note=PAC | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 89_142 | 81.66666666666667 | 776.0 | Domain | bHLH | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 112_168 | 90.66666666666667 | 790.0 | Region | Required for heterodimer formation with HIF1A | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 112_264 | 90.66666666666667 | 790.0 | Region | Required for heterodimer formation with EPAS1 | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 167_171 | 90.66666666666667 | 790.0 | Region | Mediates the transcription activity and dimerization of the AHR:ARNT complex | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000358595 | 4 | 22 | 88_128 | 90.66666666666667 | 790.0 | Region | DNA-binding | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 112_168 | 75.66666666666667 | 775.0 | Region | Required for heterodimer formation with HIF1A | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 112_264 | 75.66666666666667 | 775.0 | Region | Required for heterodimer formation with EPAS1 | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 167_171 | 75.66666666666667 | 775.0 | Region | Mediates the transcription activity and dimerization of the AHR:ARNT complex | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000505755 | 3 | 21 | 88_128 | 75.66666666666667 | 775.0 | Region | DNA-binding | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 112_168 | 81.66666666666667 | 776.0 | Region | Required for heterodimer formation with HIF1A | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 112_264 | 81.66666666666667 | 776.0 | Region | Required for heterodimer formation with EPAS1 | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 167_171 | 81.66666666666667 | 776.0 | Region | Mediates the transcription activity and dimerization of the AHR:ARNT complex | |
| Tgene | ARNT | chr1:150991145 | chr1:150812130 | ENST00000515192 | 5 | 23 | 88_128 | 81.66666666666667 | 776.0 | Region | DNA-binding |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | PRUNE | chr1:150991145 | chr1:150812130 | ENST00000368934 | + | 1 | 4 | 106_108 | 0 | 219.0 | Motif | Note=DHH motif |
| Hgene | PRUNE | chr1:150991145 | chr1:150812130 | ENST00000368935 | + | 1 | 4 | 106_108 | 0 | 169.0 | Motif | Note=DHH motif |
| Hgene | PRUNE | chr1:150991145 | chr1:150812130 | ENST00000368936 | + | 1 | 7 | 106_108 | 0 | 272.0 | Motif | Note=DHH motif |
| Hgene | PRUNE | chr1:150991145 | chr1:150812130 | ENST00000368937 | + | 1 | 4 | 106_108 | 0 | 219.0 | Motif | Note=DHH motif |
| Hgene | PRUNE | chr1:150991145 | chr1:150812130 | ENST00000271620 | + | 3 | 8 | 393_420 | 111.66666666666667 | 454.0 | Region | Note=Essential for homodimerization |
| Hgene | PRUNE | chr1:150991145 | chr1:150812130 | ENST00000368934 | + | 1 | 4 | 393_420 | 0 | 219.0 | Region | Note=Essential for homodimerization |
| Hgene | PRUNE | chr1:150991145 | chr1:150812130 | ENST00000368935 | + | 1 | 4 | 393_420 | 0 | 169.0 | Region | Note=Essential for homodimerization |
| Hgene | PRUNE | chr1:150991145 | chr1:150812130 | ENST00000368936 | + | 1 | 7 | 393_420 | 0 | 272.0 | Region | Note=Essential for homodimerization |
| Hgene | PRUNE | chr1:150991145 | chr1:150812130 | ENST00000368937 | + | 1 | 4 | 393_420 | 0 | 219.0 | Region | Note=Essential for homodimerization |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| PRUNE | |
| ARNT |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to PRUNE-ARNT |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to PRUNE-ARNT |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies